New research from Florida State University could link chemotherapy mixtures to the tumour cells of an individual patient, making chemo treatments more personalised and more effective.
Steven Lenhert, a Florida State biology assistant professor and principal investigator on the research effort, has developed new technology that could significantly decrease the cost of drug discovery, and possibly lead to better care for cancer patients.
Lenhert said: “Right now, cancer patients receive chemotherapy treatments that are based on the accumulated knowledge of what has worked best for people with similar cancers.” However, with the new technology, treatments could become more personalised.
Lenhert's invention works by miniaturizing the first phase of a process used by pharmaceutical companies to discover new drugs. Currently, making new drugs is a laborious process which can be expensive and take a lot of time. However, the new technology uses liposome microarrays to analyse basically collections of drug-containing oil drops on a surface, making the processes much cheaper and very time efficient.